Comparison of Urinary Ace 2 Levels in Individuals with Hypertension and Type 2 Diabetes with Individuals who have Hypertension but not Diabetes

Mah-E-Jabeen Sear, S. Naeem, S. Mukhtar, Shaista Hussain, Iram Qamar, Javaria Latif
{"title":"Comparison of Urinary Ace 2 Levels in Individuals with Hypertension and Type 2 Diabetes with Individuals who have Hypertension but not Diabetes","authors":"Mah-E-Jabeen Sear, S. Naeem, S. Mukhtar, Shaista Hussain, Iram Qamar, Javaria Latif","doi":"10.53350/pjmhs202317675","DOIUrl":null,"url":null,"abstract":"Background: In this investigation, the levels of urine Angiotensin Converting Enzyme(ACE2)in patients with Type 2 diabetes and high blood pressure were evaluated and their results compared in individuals having raised blood pressure but they had normal blood sugar control. Given the growing body of evidence linking ACE 2 insufficiency to the etiology of hypertension in diabetic patients, we hoped to find higher Angiotensin Converting Enzyme2 levels in the urine of hypertensive diabetic patients than in those without diabetes. Aim: As a result, new pathways for the development of antihypertensive medicines aimed at protecting Angiotensin Converting Enzyme2, particularly in diabetic patients, may open up. Methods: Two groups, each with 49 subjects, were created from a population of chosen subjects.Patients with diabetes and hypertension were chosen from the Services Institute of Medical Sciences diabetic clinic and medical wards in Lahore. In the clinics, anthropometric characteristics and blood sugar levels were recorded. In the Physiology Laboratory at University of Health Sciences, blood samples were obtained and maintained in order to evaluate biochemical characteristics. Results: We calculated the median value in each group because the data for urine Angiotensin Converting Enzyme 2 readings was not dispersedevenly. Non-diabetic hypertension participants had a median of 26.47mg/dl, while hypertensivediabetic subjects had a median of 22.86mg/dl. This difference in ACE 2 levels in the urine was statistically significant (p0.05). Non-diabetic, hypertension patients had greater urinary Angiotensin Converting Enzyme 2 levels than diabetic, hypertensive patients. Conclusion: Contrary to our expectations, we were unable to confirm that urine Angiotensin Converting Enzyme 2 readingsare higher in people with high arterial pressure and type 2 diabetes mellitus. This is despite the fact that the current study confirmed that both type 2 diabetes mellitus and hypertension are risk factors for chronic kidney disease. Key words: Renin Aldosterone-Angiotensin System, urinary Angiotensin Converting Enzyme 2 levels, Chronic Kidney Disease","PeriodicalId":19842,"journal":{"name":"Pakistan Journal of Medical and Health Sciences","volume":"25 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pakistan Journal of Medical and Health Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.53350/pjmhs202317675","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Background: In this investigation, the levels of urine Angiotensin Converting Enzyme(ACE2)in patients with Type 2 diabetes and high blood pressure were evaluated and their results compared in individuals having raised blood pressure but they had normal blood sugar control. Given the growing body of evidence linking ACE 2 insufficiency to the etiology of hypertension in diabetic patients, we hoped to find higher Angiotensin Converting Enzyme2 levels in the urine of hypertensive diabetic patients than in those without diabetes. Aim: As a result, new pathways for the development of antihypertensive medicines aimed at protecting Angiotensin Converting Enzyme2, particularly in diabetic patients, may open up. Methods: Two groups, each with 49 subjects, were created from a population of chosen subjects.Patients with diabetes and hypertension were chosen from the Services Institute of Medical Sciences diabetic clinic and medical wards in Lahore. In the clinics, anthropometric characteristics and blood sugar levels were recorded. In the Physiology Laboratory at University of Health Sciences, blood samples were obtained and maintained in order to evaluate biochemical characteristics. Results: We calculated the median value in each group because the data for urine Angiotensin Converting Enzyme 2 readings was not dispersedevenly. Non-diabetic hypertension participants had a median of 26.47mg/dl, while hypertensivediabetic subjects had a median of 22.86mg/dl. This difference in ACE 2 levels in the urine was statistically significant (p0.05). Non-diabetic, hypertension patients had greater urinary Angiotensin Converting Enzyme 2 levels than diabetic, hypertensive patients. Conclusion: Contrary to our expectations, we were unable to confirm that urine Angiotensin Converting Enzyme 2 readingsare higher in people with high arterial pressure and type 2 diabetes mellitus. This is despite the fact that the current study confirmed that both type 2 diabetes mellitus and hypertension are risk factors for chronic kidney disease. Key words: Renin Aldosterone-Angiotensin System, urinary Angiotensin Converting Enzyme 2 levels, Chronic Kidney Disease
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
高血压合并2型糖尿病患者与高血压非糖尿病患者尿Ace 2水平的比较
背景:本研究评估了2型糖尿病合并高血压患者的尿血管紧张素转换酶(ACE2)水平,并将其结果与血压升高但血糖控制正常的个体进行了比较。鉴于越来越多的证据表明ACE 2不足与糖尿病患者高血压的病因有关,我们希望发现高血压糖尿病患者尿液中的血管紧张素转换酶2水平高于非糖尿病患者。目的:因此,开发旨在保护血管紧张素转换酶2的降压药物,特别是糖尿病患者,可能会开辟新的途径。方法:从选定的受试者群体中创建两组,每组49名受试者。糖尿病和高血压患者是从拉合尔医学科学服务研究所糖尿病诊所和病房中挑选出来的。在诊所,记录了人体测量特征和血糖水平。在健康科学大学生理学实验室,采集并保存血液样本,以评估生化特征。结果:我们计算了每组的中位数,因为尿血管紧张素转换酶2读数的数据并不分散。非糖尿病高血压患者的中位数为26.47mg/dl,而高血压糖尿病患者的中位数为22.86mg/dl。尿中ACE 2水平差异有统计学意义(p0.05)。非糖尿病、高血压患者尿血管紧张素转换酶2水平高于糖尿病、高血压患者。结论:与我们的预期相反,我们无法证实高血压和2型糖尿病患者的尿血管紧张素转换酶2读数更高。尽管目前的研究证实,2型糖尿病和高血压都是慢性肾脏疾病的危险因素。关键词:肾素醛固酮-血管紧张素系统,尿血管紧张素转换酶2水平,慢性肾病
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Clinical Profile and Outcomes of Primary PCI in Patients with Acute STEMI The Prevalence of BRCA1 and BRCA2 Mutations in Breast Cancer Patients Association Between Body Mass Index (BMI) and Occurrence of Esophageal Cancer Effects of Dietary Factors on Gastroesophageal Reflux Disease (GERD) Among the Student and Faculty of Public and Private Medical Universities of Karachi, Pakistan Positivity of BRCA 1 & 2 Mutations in Ovarian Cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1